NCT00969592 - Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

June 30, 2008

Conditions

Diabetes

Interventions

DRUG

insulin glulisine, insulin aspart

single subcutaneous dose of 0.2 units per kg body weight of insulin glulisine during first euglycemic glucose clamp, single subcutaneous dose of 0.2 units per kg body weight of insulin aspart during second euglycemic glucose clamp

DRUG

insulin aspart, insulin glulisine

single subcutaneous dose of 0.2 units per kg body weight of insulin aspart during first euglycemic glucose clamp, single subcutaneous dose of 0.2 units per kg body weight of insulin glulisine during second euglycemic glucose clamp

Trial Locations (1)

D-41460

Profil Institut für Stoffwechselforschung GmbH, Neuss